Minakami S, Kakinuma K, Takeshige K. Leukocytes and Biological Defence. Tokyo, Japan: Kodansha, 1990.
Swank DW, Moore SB. Roles of the neutrophil and other mediators in adult respiratory distress syndrome. Mayo Clin Proc 1989; 64: 1118–1132.
Irita K, Fujita I, Takeshige K, Minakami S, Yoshitake J. Cinchocaine and amethocaine inhibit activation and activity of superoxide production in human neutrophils. Br J Anaesth 1986; 58: 639–645.
Sasagawa S. Inhibitory effects of local anesthetics on migration, extracellular release of lysosomal enzyme, and superoxide anion production in human polymorphonuclear leukocytes. Immunopharmacol Immunotoxicol 1991; 13: 607–622.
Hattori M, Dohi S, Nozaki M, Niwa M, Shimonaka H. The inhibitory effects of local anesthetics on superoxide generation of neutrophils correlate with their partition coefficients. Anesth Analg 1997; 84: 405–412.
Cederholm I, Briheim G, Rutberg H, Dahlgren C. Effects of five amino-amide local anaesthetic agents on human polymorphonuclear leukocytes measured by chemiluminescence. Acta Anaesthesiol Scand 1994; 38: 704–710.
Hyvonen PM, Kowolik MJ. Dose-dependent suppression of the neutrophil respiratory burst by lidocaine. Acta Anaesthesiol Scand 1998; 42: 565–569.
Gasparoni A, De-Amici D, Ciardelli L, et al. Effect of lidocaine on neutrophil chemotaxis in newborn infants. J Clin Immunol 1998; 18: 210–213.
Hammer R, Dahlgren C, Stendahl O. Inhibition of human leukocyte metabolism and random mobility by local anaesthesia. Acta Anaesthesiol Scand 1985; 29: 520–523.
Mikawa K, Akamatsu H, Nishina K, et al. Inhibitory effect of local anaesthetics on reactive oxygen species production by human neutrophils. Acta Anaesthesiol Scand 1997; 41: 524–528.
Vitola JV, Forman MB, Holsinger JP, Atkinson JB, Murray JJ. Reduction of myocardial infarct size in rabbits and inhibition of activation of rabbit and human neutrophils by lidocaine. Am Heart J 1997; 133: 315–322.
Lesnefsky EJ, VanBenthuysen KM, McMurtry IF, Shikes RH, Johnston RB Jr, Horwitz LD. Lidocaine reduces canine infarct size and decreases release of a lipid peroxidation product. J Cardiovasc Pharmacol 1989; 13: 895–901.
Peck SL, Johnston RB, Jr, Horwitz LD. Reduced neutrophil superoxide anion release after prolonged infusions of lidocaine. J Pharmacol Exp Ther 1985; 235: 418–422.
Takao Y, Mikawa K, Nishina K, Maekawa N, Obara H. Lidocaine attenuates hyperoxic lung injury in rabbits. Acta Anaesthesiol Scand 1996; 40: 318–325.
Mikawa K, Maekawa N, Nishina K, Takao Y, Yaku H, Obara H. Effect of lidocaine pretreatment on endotoxin-induced lung injury in rabbits. Anesthesiology 1994; 81: 689–699.
Finucane BT, Sandler AN, McKenna J, et al. A double-blind comparison of ropivacaine 0.5, 0.75, 1.0% and bupivacaine 0.5%, injected epidurally, in patients undergoing abdominal hysterectomy. Can J Anaesth 1996; 43: 442–449.
Welters ID, Menzebach A, Langefeld TW, Menzebach M, Hempelmann G. Inhibitory effects of S-(−) and R-(+) bupivacaine on neutrophil function. Acta Anaesthesiol Scand 2001; 45: 570–575.
Mamiya K, Tomoda MK, Edashige K, Ueda W, Manabe M. Local anesthetics enhance nitric oxide production by human peripheral neutrophils. Physiol Chem Phys Med NMR 1995; 27: 111–119.
Haines KA, Reibman J, Callegari PE, Abramson SB, Philips MR, Weissmann G. Cocaine and its derivatives blunt neutrophil functions without influencing phosphorylation of a 47-kilodalton component of the reduced nicotinamide-adenine dinucleotide phosphate oxidase. J Immunol 1990; 144: 4757–4764.
Miyachi Y, Yoshioka A, Imamura S, Niwa Y. Anti-oxidant effects of gold compounds. Br J Dermatol 1987; 116: 39–46.
Mikawa K, Akamatsu H, Nishina K, et al. The effect of phosphodiesterase III inhibitors on human neutrophil function. Crit Care Med 2000; 28: 1001–1005.
Wulf H, Behnke H, Vogel I, Schroder L. Clinical usefulness, safety, and plasma concentration of ropivacaine 0.5% for inguinal hernia repair in regional anesthesia. Reg Anesth Pain Med 2001; 26: 348–351.
Gin T, Chan K, Kan AF, Gregory MA, Wong YC, Oh TE. Effect of adrenaline on venous plasma concentrations of bupivacaine after interpleural administration. Br J Anaesth 1990; 64: 662–666.
Mather LE, Tucker GT, Murphy TM, Stanton-Hicks DA, Bonica JJ. The effects of adding adrenaline to etidocaine and lignocaine in extradural anaesthesia. II: Pharmacokinetics. Br J Anaesth 1976; 48: 989–994.
Mikawa K, Akamatsu H, Nishina K, Shiga M, Obara H, Niwa Y. Inhibitory effects of pentobarbital and phenobarbital on human neutrophil functions. J Intensive Care Med 2001; 16: 9–87.
Kruger NJ. The Bradford method for protein quantitation. Methods Mol Biol 1994; 32: 9–15.
Lew DP, Andersson T, Hed J, Di-Virgilio F, Pozzan T, Stendahl O. Ca2+-dependent and Ca2+-independent phagocytosis in human neutrophils. Nature 1985; 315: 509–511.
Santoro P, Agosti V, Viggiano D, Palumbo A, Sarno T, Ciccumarra F. Impaired d-myo-inositol 1,4,5-triphosphate generation from cord blood polymorphonuclear leukocytes. Pediatr Res 1995; 38: 564–567.
Thomas JM, Schug SA. Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions. Clin Pharmacokinet 1999; 36: 67–83.
Kondo Y, Kondo F, Asanuma M, Tanaka K, Ogawa N. Protective effect of orengedoku-to against induction of neuronal death by transient cerebral ischemia in the C57BL/6 mouse. Neurochem Res 2000; 25: 205–209.
Qayumi AK, Janusz MT, Jamieson WR, Lyster DM. Pharmacologic interventions for prevention of spinal cord injury caused by aortic crossclamping. J Thorac Cardiovasc Surg 1992; 104: 256–261.
Ryoke K, Osaki T, Hamada T. The study of local anesthetics. I. Gas-chromatographed lidocaine concentration in blood, urine and in the injected tissue. J Jpn Dent Soc Anesthesiol 1980; 8: 182–193.
Eriksson AS, Sinclair R, Cassuto J, Thomsen P. Influence of lidocaine on leukocyte function in the surgical wound. Anesthesiology 1992; 77: 74–78.